HealthEquity (NASDAQ:HQY) Upgraded by Wall Street Zen to "Buy" Rating

Key Points

• Wall Street Zen upgraded HealthEquity from “hold” to “buy,” while the broader analyst consensus remains “Moderate Buy” with an average price target of $110.93.
• HealthEquity reported quarterly EPS of $1.24, exceeding the $1.11 consensus estimate, while revenue rose 7.2% year over year to $354.64 million.
• Shares opened at $105.41, near their 52-week high of $107.62; insiders have sold $1.65 million worth of stock over the past three months, while institutional investors own 99.55% of shares.

HealthEquity (NASDAQ:HQY - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report issued on Saturday.

A number of other research analysts also recently commented on HQY. KeyCorp reaffirmed an "overweight" rating on shares of HealthEquity in a report on Tuesday, May 26th. Barrington Research restated an "outperform" rating and set a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research note on Monday, June 1st. Weiss Ratings upgraded HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a report on Friday, June 5th. Finally, Citigroup reissued a "market outperform" rating on shares of HealthEquity in a research report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of "Moderate Buy" and an average target price of $110.93.

HealthEquity Trading Up 1.1%

Shares of HQY opened at $105.41 on Friday. The company's fifty day moving average is $96.64 and its 200 day moving average is $87.20. HealthEquity has a fifty-two week low of $72.76 and a fifty-two week high of $107.62. The stock has a market capitalization of $8.81 billion, a PE ratio of 39.48, a P/E/G ratio of 1.75 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The business's revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts expect that HealthEquity will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company's stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares of the company's stock, valued at $1,775,970. This represents a 11.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by company insiders.

Institutional Trading of HealthEquity

A number of large investors have recently made changes to their positions in the stock. Acumen Wealth Advisors LLC purchased a new position in HealthEquity in the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd boosted its position in HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock valued at $28,000 after buying an additional 293 shares during the period. Aster Capital Management DIFC Ltd bought a new position in HealthEquity in the 4th quarter worth about $28,000. Leonteq Securities AG grew its stake in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company's stock worth $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC bought a new position in HealthEquity in the 1st quarter worth about $33,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source